Bristol Myers (BMY) Squibb announced that the European Commission has granted approval to Breyanzi, a CD19-directed chimeric antigen receptor T cell therapy, for the treatment of adult patients ...

2-Year U.S. Treasury Note Continuous Contract $103.402-0.043-0.04% 5-Year U.S. Treasury Note Continuous Contract $107.711-0.086-0.08% 10-Year U.S. Treasury Note Continuous Contract $110.641-0.109 ...

Protecting and conserving our natural heritage, predicting weather and environmental conditions, preventing and managing pollution, promoting clean growth and a sustainable environment for present and ...